Sign Up Today and Learn More About ORIC Pharmaceuticals Stock

Invest in or calculate the value of your shares in ORIC Pharmaceuticals or other pre-IPO companies through EquityZen's platform.

Get Started

ORIC Pharmaceuticals Stock

Biopharmaceutical company

About ORIC Pharmaceuticals Stock

Founded

2014

Headquarters

South San Francisco, CA, US

Notable Investor

Taiho Ventures

Total Funding

178M

ORIC Pharmaceuticals is a privately-held company dedicated to discovering and developing novel therapies for treatment-resistant cancers. While recent advances with targeted therapeutics have extended prognoses in many disease settings, cancers often develop resistance to current drugs. Relapsed patients lack further treatment options. ORIC has assembled a world-class scientific team dedicated to the discovery of therapies that can meaningfully improve clinical outcomes for these patients.

Investors in ORIC Pharmaceuticals

Discover investors in ORIC Pharmaceuticals stock and explore their portfolio companies

ORIC Pharmaceuticals Management

Leadership team at ORIC Pharmaceuticals

Chief Executive Officer

Jacob Chacko

Chief Scientific Officer

Lori Friedman

Locked Features

Join now and verify your accreditation status to gain access to:

  • ORIC Pharmaceuticals current valuation
  • ORIC Pharmaceuticals stock price
  • Available deals in ORIC Pharmaceuticals and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in ORIC Pharmaceuticals stock?

Accredited investors can buy pre-IPO stock in companies like ORIC Pharmaceuticals through EquityZen funds. These investments are made available by existing ORIC Pharmaceuticals shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell ORIC Pharmaceuticals stock?

Shareholders can sell their ORIC Pharmaceuticals stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."